# reload+after+2024-01-20 21:45:52.984993
address1§700 Chesapeake Drive
city§Redwood City
state§CA
zip§94063
country§United States
phone§650 364 0400
website§https://pulmonx.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.
fullTimeEmployees§269
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Glendon E. French', 'age': 61, 'title': 'CEO, President & Director', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 892290, 'exercisedValue': 0, 'unexercisedValue': 973431}, {'maxAge': 1, 'name': 'Mr. David A. Lehman', 'age': 62, 'title': 'General Counsel & Secretary', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 571591, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Geoffrey Beran Rose', 'age': 49, 'title': 'Chief Commercial Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 560279, 'exercisedValue': 0, 'unexercisedValue': 653549}, {'maxAge': 1, 'name': 'Mr. John B. McKune', 'age': 47, 'title': 'Interim CFO', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sri  Radhakrishnan', 'title': 'Chief Technical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Marcee M. Maroney', 'age': 53, 'title': 'Vice President of Marketing', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Sarah  Huber', 'title': 'Vice President of Sales (U.S.)', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Lisa  Paul', 'age': 59, 'title': 'Chief People Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jérôme  Erath', 'title': 'Senior VP & GM of Europe Middle-East & Africa', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§6
compensationRisk§10
shareHolderRightsRisk§8
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.721
priceToSalesTrailing12Months§7.079865
currency§USD
dateShortInterest§1702598400
forwardEps§-1.59
pegRatio§-0.36
exchange§NMS
quoteType§EQUITY
shortName§Pulmonx Corporation
longName§Pulmonx Corporation
firstTradeDateEpochUtc§1601559000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e6c2e6bc-5375-39f3-b953-9a49b1ec8ea8
gmtOffSetMilliseconds§-18000000
targetHighPrice§18.0
targetLowPrice§13.0
targetMeanPrice§15.33
targetMedianPrice§15.0
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§6
quickRatio§6.219
grossMargins§0.73333
ebitdaMargins§-0.94098
trailingPegRatio§None
